Epilepsy research in 2022: clinical advances

Most notably, in May 2022, the World Health Assembly adopted the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders, which aims to address gaps in health care delivery, with epilepsy as a core focus.1 Many research groups have previously investigated how to use enhanced imaging technologies to produce clinically useful data for the characterisation of individual outcomes and prognosis for epilepsy, but these efforts have typically had little success. An example of such an intervention was assessed by Streltzov and colleagues,8 who showed the effectiveness of a home-based virtual version of an epilepsy self-management programme at improving quality of life. In survivors of cardiac arrest who were comatose, the incidence of poor neurological outcome 3 months after hospital admission did not differ between individuals who had their periodic pattern suppressed for at least 48 h and those who received standard care.